/anm-english/media/agency_attachments/AtBG5e3MoE629QYzhZen.png)
/ )
New Update
/anm-english/media/post_banners/eyz1XQvVOyzMB60yMNJm.jpg)
BY A STAFF REPORTER
US FDA:Major deviation in good mfg practice in Aurobindo Pharma unit
CONTEXT:Aurobindo Pharma Telangana unit got US FDA warning letter
US FDA: Repeat deviations in good mfg practice by Aurobindo Pharma
US FDA: Aurobindo Pharma unit fails to assess bulk drug impurities
US FDA:Aurobindo Pharma must appoint consultant for norm compliance
Source : Eureka
Please register at https://kyc.eurekasecurities.net/home/index/729 for opening Trading and Demat Account.